Rapid Dose Therapeutics Extends Strategic Collaboration with Global Nicotine Leader and Initiating Saudi Arabia Commercialization

Source Summary

Burlington, Ontario--(Newsfile Corp. - July 7, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) ("RDT" or the "Company"), a Canadian biotechnology company specializing in oral thin film drug delivery technology, is pleased to announce the execution of a Memorandum of Understanding ("MOU") with a global leader in the nicotine products industry, extending the parties' ongoing collaboration surrounding RDT's proprietary QuickStripTM dissolvable oral nicotine strip